Social Pulse: Eli Lilly and Co (LLY.F)
LLY.F on Frankfurt Stock Exchange
30 Jan 2015
30 Jan 2015
Change (% chg)
- Eli Lilly's (LLY) CEO John Lechleiter on Q4 2014 Results - Earnings Call Transcript
- Drugmaker Eli Lilly's Q4 Profits Slide on Back of Stronger Dollar
- Eli Lilly and (LLY) Q4 2014 Results - Earnings Call Webcast
- Google, Amazon Earnings in Focus; Shake Shack Begins Trade
- $CTIX - Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon
- What to Expect When Eli Lilly (LLY) Reports Fourth-Quarter Earnings Tomorrow
- Analyst Opinion on Eli Lilly & Co. and Pfizer Inc. -- Drug Manufacturers Countering Patent Expirations with New Products
- Market Influences That Drive Equities Forward -- Industry Report on Eli Lilly And Company and Stericycle, Inc.
- A Refreshing Outlook - Consensus Reports on Arena Pharmaceuticals, Inc. and Eli Lilly and Company
- Where We Are Headed -- New Outlook on Eli Lilly and Company and Arena Pharmaceuticals, Inc.
- FDA Approves ERBITUX(R) (cetuximab) as First-Line Treatment in KRAS Mutation-Negative (Wild-Type) Epidermal Growth Factor Receptor (EGFR)-Expressing Metastatic Colorectal Cancer in Combination with FOLFIRI (Irinotecan, 5-Flu